$ALXA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Alexza Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Alexza Pharmaceuticals Inc.. Get notifications about new insider transactions in Alexza Pharmaceuticals Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2016 | ALXA | Alexza Pharmaceuti ... | Grupo Ferrer Internacional, S. ... | 10% Owner | Buy | P | 0.90 | 19,465,714 | 17,519,143 | 21,832,649 | 2.4 M to 21.8 M (+822.40 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D, Regulator ... | Option Exercise | D | 15.30 | 9,999 | 152,985 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D, Regulator ... | Option Exercise | D | 4.57 | 24,000 | 109,680 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D, Regulator ... | Option Exercise | D | 4.42 | 43,750 | 193,375 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D, Regulator ... | Option Exercise | D | 3.47 | 5,000 | 17,350 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D, Regulator ... | Option Exercise | D | 3.47 | 15,000 | 52,050 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D, Regulator ... | Option Exercise | D | 1.95 | 35,000 | 68,250 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D, Regulator ... | Option Exercise | D | 1.08 | 125,000 | 135,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D, Regulator ... | Sell | U | 0.00 | 9,112 | 0 | 0 | 9.1 K to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Option Exercise | D | 21.00 | 5,453 | 114,513 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Option Exercise | D | 23.70 | 9,921 | 235,128 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Option Exercise | D | 15.30 | 19,576 | 299,513 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Option Exercise | D | 3.47 | 33,449 | 116,068 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Option Exercise | D | 4.42 | 50,001 | 221,004 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Option Exercise | D | 4.57 | 50,000 | 228,500 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Option Exercise | D | 1.08 | 400,000 | 432,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Option Exercise | D | 27.70 | 5,819 | 161,187 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Sell | U | 0.00 | 40,000 | 0 | 0 | 40 K to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President & CEO | Sell | U | 0.00 | 37,224 | 0 | 0 | 37.2 K to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | D | 28.00 | 2,500 | 70,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | D | 15.30 | 3,125 | 47,813 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | D | 3.50 | 3,991 | 13,969 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | D | 4.68 | 11,606 | 54,316 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | D | 4.35 | 12,500 | 54,375 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | D | 1.28 | 12,500 | 16,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Sell | U | 0.00 | 1,050 | 0 | 0 | 1.1 K to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 98.50 | 625 | 61,563 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 53.30 | 625 | 33,313 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 16.90 | 625 | 10,563 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 35.20 | 625 | 22,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 15.30 | 3,125 | 47,813 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 3.50 | 3,991 | 13,969 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 4.68 | 11,606 | 54,316 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 4.35 | 12,500 | 54,375 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | D | 1.28 | 12,500 | 16,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Sell | U | 0.00 | 15,838 | 0 | 0 | 15.8 K to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 98.50 | 625 | 61,563 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 53.30 | 625 | 33,313 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 16.90 | 625 | 10,563 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 35.20 | 625 | 22,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 15.30 | 3,125 | 47,813 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 3.50 | 3,991 | 13,969 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 4.68 | 11,606 | 54,316 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 4.35 | 12,500 | 54,375 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | D | 1.28 | 12,500 | 16,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Sell | U | 0.00 | 927 | 0 | 0 | 927 to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Sell | U | 0.00 | 927 | 0 | 0 | 927 to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Sell | U | 0.00 | 32,392 | 0 | 0 | 32.4 K to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 98.50 | 625 | 61,563 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 53.30 | 625 | 33,313 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 16.90 | 625 | 10,563 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 35.20 | 625 | 22,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 15.30 | 3,125 | 47,813 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 3.50 | 3,991 | 13,969 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 4.68 | 11,606 | 54,316 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 4.35 | 12,500 | 54,375 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | D | 1.28 | 12,500 | 16,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Sell | U | 0.00 | 3,492 | 0 | 0 | 3.5 K to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 98.50 | 625 | 61,563 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 53.30 | 625 | 33,313 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 16.90 | 625 | 10,563 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 35.20 | 625 | 22,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 15.30 | 3,125 | 47,813 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 3.50 | 3,991 | 13,969 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 4.68 | 11,606 | 54,316 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 4.35 | 12,500 | 54,375 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | D | 1.28 | 12,500 | 16,000 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Sell | U | 0.00 | 98,967 | 0 | 0 | 99 K to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Sell | U | 0.00 | 658 | 0 | 0 | 658 to 0 (-100.00 %) |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | D | 5.13 | 20,000 | 102,600 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | D | 4.35 | 12,500 | 54,375 | 0 | |
Jun 21 2016 | ALXA | Alexza Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | D | 1.28 | 12,500 | 16,000 | 0 | |
Sep 28 2015 | ALXA | Alexza Pharmaceuti ... | Grupo Ferrer Internacional, S. ... | 10% Owner | Buy | P | 0.00 | 125,000 | 0 | 2,366,935 | 2.2 M to 2.4 M (+5.58 %) |
Jul 24 2015 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D and Qualit ... | Option Exercise | A | 1.08 | 125,000 | 135,000 | 125,000 | |
Jul 24 2015 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, Finance, CFO & ... | Option Exercise | A | 1.08 | 125,000 | 135,000 | 125,000 | |
Jul 24 2015 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President and CEO | Option Exercise | A | 1.08 | 400,000 | 432,000 | 400,000 | |
Jun 25 2015 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | A | 1.28 | 12,500 | 16,000 | 12,500 | |
Jun 25 2015 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 1.28 | 12,500 | 16,000 | 12,500 | |
Jun 25 2015 | ALXA | Alexza Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | A | 1.28 | 12,500 | 16,000 | 12,500 | |
Jun 25 2015 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | A | 1.28 | 12,500 | 16,000 | 12,500 | |
Jun 25 2015 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | A | 1.28 | 12,500 | 16,000 | 12,500 | |
Jun 25 2015 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | A | 1.28 | 12,500 | 16,000 | 12,500 | |
Apr 29 2015 | ALXA | Alexza Pharmaceuti ... | Kamemoto Edwin S | EVP, R&D and Qualit ... | Option Exercise | A | 1.95 | 35,000 | 68,250 | 35,000 | |
Jul 08 2014 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Option Exercise | A | 4.45 | 25,000 | 111,250 | 25,000 | |
Jun 30 2014 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO & Secretar ... | Option Exercise | A | 4.57 | 50,000 | 228,500 | 50,000 | |
Jun 30 2014 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | President and CEO | Option Exercise | A | 4.57 | 100,000 | 457,000 | 100,000 | |
Jun 30 2014 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Option Exercise | A | 4.57 | 125,000 | 571,250 | 125,000 | |
Jun 11 2014 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jun 11 2014 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jun 11 2014 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jun 11 2014 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jun 11 2014 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Jun 11 2014 | ALXA | Alexza Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | A | 4.35 | 12,500 | 54,375 | 12,500 | |
Sep 09 2013 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Buy | P | 4.77 | 10,000 | 47,700 | 32,392 | 22.4 K to 32.4 K (+44.66 %) |
Jul 26 2013 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Buy | P | 4.49 | 2,420 | 10,866 | 215,000 | 212.6 K to 215 K (+1.14 %) |
Jul 26 2013 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Buy | P | 4.50 | 12,580 | 56,585 | 212,580 | 200 K to 212.6 K (+6.29 %) |
Jul 26 2013 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Buy | P | 4.48 | 25,000 | 111,900 | 200,000 | 175 K to 200 K (+14.29 %) |
May 22 2013 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | A | 4.68 | 11,606 | 54,316 | 11,606 | |
May 22 2013 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | A | 4.68 | 11,606 | 54,316 | 11,606 | |
May 22 2013 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | A | 4.68 | 11,606 | 54,316 | 11,606 | |
May 22 2013 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 4.68 | 11,606 | 54,316 | 11,606 | |
May 22 2013 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | A | 4.68 | 11,606 | 54,316 | 11,606 | |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Schineller Peter W. | SVP and CCO | Option Exercise | A | 4.42 | 87,500 | 386,750 | 87,500 | |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Schineller Peter W. | SVP and CCO | Grant | A | 4.42 | 43,750 | 193,375 | 43,750 | 0 to 43.8 K |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Option Exercise | A | 4.42 | 87,500 | 386,750 | 87,500 | |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Grant | A | 4.42 | 43,750 | 193,375 | 47,998 | 4.2 K to 48 K (+1,029.90 %) |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Buy | W | 0.00 | 68 | 0 | 4,248 | 4.2 K to 4.2 K (+1.63 %) |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Option Exercise | A | 4.42 | 87,500 | 386,750 | 87,500 | |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Grant | A | 4.42 | 43,750 | 193,375 | 49,538 | 5.8 K to 49.5 K (+755.87 %) |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Option Exercise | A | 4.42 | 43,750 | 193,375 | 43,750 | |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Grant | A | 4.42 | 43,750 | 193,375 | 62,495 | 18.7 K to 62.5 K (+233.40 %) |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | A | 4.42 | 350,000 | 1,547,000 | 350,000 | |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Grant | A | 4.42 | 175,000 | 773,500 | 175,000 | 0 to 175 K |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Moreland Darl | SVP, Quality | Option Exercise | A | 4.42 | 87,500 | 386,750 | 87,500 | |
Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Moreland Darl | SVP, Quality | Grant | A | 4.42 | 43,750 | 193,375 | 47,299 | 3.5 K to 47.3 K (+1,232.74 %) |
Feb 08 2013 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Grant | A | 0.00 | 17,795 | 0 | 18,745 | 950 to 18.7 K (+1,873.16 %) |
Feb 27 2013 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Gift | G | 0.00 | 9,113 | 0 | 30,149 | 21 K to 30.1 K (+43.32 %) |
Feb 27 2013 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Gift | G | 0.00 | 9,113 | 0 | 0 | 9.1 K to 0 (-100.00 %) |
Jan 22 2013 | ALXA | Alexza Pharmaceuti ... | LANSDOWNE PARTNERS AUSTRIA GMB ... | 10% Owner | Sell | S | 4.75 | 25,000 | 118,750 | 1,520,055 | 1.5 M to 1.5 M (-1.62 %) |
Jan 22 2013 | ALXA | Alexza Pharmaceuti ... | LANSDOWNE PARTNERS AUSTRIA GMB ... | 10% Owner | Sell | S | 4.75 | 100,000 | 475,000 | 1,545,055 | 1.6 M to 1.5 M (-6.08 %) |
Dec 31 2012 | ALXA | Alexza Pharmaceuti ... | LANSDOWNE PARTNERS AUSTRIA GMB ... | 10% Owner | Buy | P | 4.84 | 28,589 | 138,371 | 1,645,055 | 1.6 M to 1.6 M (+1.77 %) |
Dec 31 2012 | ALXA | Alexza Pharmaceuti ... | LANSDOWNE PARTNERS AUSTRIA GMB ... | 10% Owner | Buy | P | 4.86 | 43,600 | 211,896 | 1,616,466 | 1.6 M to 1.6 M (+2.77 %) |
Dec 27 2012 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Sell | S | 4.90 | 4,558 | 22,316 | 4,180 | 8.7 K to 4.2 K (-52.16 %) |
Dec 27 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Sell | S | 4.90 | 4,558 | 22,316 | 950 | 5.5 K to 950 (-82.75 %) |
Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Sell | S | 4.14 | 10,000 | 41,364 | 5,508 | 15.5 K to 5.5 K (-64.48 %) |
Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Gift | G | 0.00 | 1,116 | 0 | 20,482 | 19.4 K to 20.5 K (+5.76 %) |
Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Gift | G | 0.00 | 1,116 | 0 | 9,113 | 10.2 K to 9.1 K (-10.91 %) |
Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 4.14 | 10,000 | 41,364 | 10,229 | 20.2 K to 10.2 K (-49.43 %) |
Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | Moreland Darl | SVP, Quality | Sell | S | 4.14 | 10,000 | 41,364 | 1,908 | 11.9 K to 1.9 K (-83.98 %) |
Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Sell | S | 4.14 | 10,000 | 41,364 | 7,957 | 18 K to 8 K (-55.69 %) |
Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Option Exercise | A | 3.47 | 25,000 | 86,750 | 25,000 | |
Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Sell | S | 4.14 | 10,000 | 41,364 | 3,788 | 13.8 K to 3.8 K (-72.53 %) |
Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Option Exercise | A | 3.47 | 25,000 | 86,750 | 25,000 | |
Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | SVP, CFO and Sec | Option Exercise | A | 3.47 | 10,000 | 34,700 | 10,000 | |
Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Option Exercise | A | 3.47 | 25,000 | 86,750 | 25,000 | |
Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Option Exercise | A | 3.47 | 15,000 | 52,050 | 15,000 | |
Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | A | 3.47 | 50,000 | 173,500 | 50,000 | |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 0.34 | 65,516 | 22,151 | 202,325 | 267.8 K to 202.3 K (-24.46 %) |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Sell | S | 0.34 | 46,222 | 15,628 | 157,801 | 204 K to 157.8 K (-22.66 %) |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | A | 0.35 | 39,918 | 13,971 | 39,918 | |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | A | 0.35 | 39,918 | 13,971 | 39,918 | |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin Controller P ... | Sell | S | 0.34 | 31,873 | 10,776 | 137,896 | 169.8 K to 137.9 K (-18.77 %) |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 0.35 | 39,918 | 13,971 | 39,918 | |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | TURNER JOSEPH L | Director | Option Exercise | A | 0.35 | 39,918 | 13,971 | 39,918 | |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Sell | S | 0.34 | 46,222 | 15,628 | 179,603 | 225.8 K to 179.6 K (-20.47 %) |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | BUSSER ANDREW L | Director | Option Exercise | A | 0.35 | 39,918 | 13,971 | 39,918 | |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | Barron Hal | Director | Option Exercise | A | 0.35 | 39,918 | 13,971 | 39,918 | |
Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | A | 0.35 | 39,918 | 13,971 | 39,918 | |
May 14 2012 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Grant | A | 0.00 | 100,000 | 0 | 267,841 | 167.8 K to 267.8 K (+59.58 %) |
May 14 2012 | ALXA | Alexza Pharmaceuti ... | Oki Mark K | VP Fin Controller P ... | Grant | A | 0.00 | 100,000 | 0 | 169,769 | 69.8 K to 169.8 K (+143.33 %) |